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Background: NT-proBtype Natriuretic Peptide (NT-proBNP) is a powerful vasodilator and natriuretic factor. We studied NT-proBNP as a predictor of 
future hypertension (HTN) in the Multiethnic Study of Atherosclerosis (MESA) cohort.
Methods: A multiethnic study population aged 45-84 years had blood pressure (BP) recorded at baseline, 1.5, 3 and 5 years and a venous blood 
sampling for NT-proBNP at baseline. We used two analysis approaches: 1) Mean NT-proBNP was studied cross-sectionally by baseline BP category; 2) 
Omitting baseline HTN (≥140/≥90 mmHg or BP lowering medication), we used proportional hazards regression to predict incident HTN.
Results: Geometric mean (GM, IQR) of NT-proBNP was 50.7 (26.5, 97.0) pg/mL. Cross-sectional analysis adjusting for age, race and sex (n = 
5596): NT-proBNP (GM ± SE) decreased then increased across BP categories: < 110/75 mmHg: 47.6 ± 1.4 pg/mL; < 120/80 mmHg: 41.9 ± 1.4 
pg/mL (P vs < 110/75 mmHg = 0.004); < 130/85 mmHg: 42.1 ± 1.6 pg/mL (P vs < 110/75 mmHg = 0.014); < 140/90 mmHg: 46.0 ± 1.9 pg/
mL; ≥ 140/90 mmHg: 61.9 ± 2.4 pg/mL; BP lowering medication: 58.9 ± 1.3 pg/mL. Further adjustment for eGFR, hsCRP, diabetes, lipids, smoking, 
BMI, heart rate, height and education led to similar findings. Longitudinal analysis adjusting for age, race, and sex (n = 870 incident HTN/2782 
without HTN at baseline) are given as hazard ratios (95 % CI) for 5 year incidence of HTN by NT-proBNP quintile (vs Q1, NT-proBNP range 5 -18 
pg/mL) were 1.28 (1.05, 1.57) (P = 0.04) for Q2 (NT-proBNP range 19 - 40 pg/mL), 1.09 (0.87, 1.36) for Q3 (NT-proBNP range 41 - 70 pg/mL), 
1.10 (0.87, 1.40) for Q4 (NT-proBNP range 71 - 135 pg/mL), 1.60 (1.24, 2.07) (P = 0.01) for Q5 (NT-proBNP range 136 - 1832 pg/mL). Findings 
strengthen with further adjustment.
Conclusions: Cross-sectionally, mean NT-proBNP was lowest in prehypertension. Longitudinally in normotensives and prehypertensives, relatively 
low NT-proBNP levels (Q2, potentially due to decreased expression) and high levels (Q5, potentially due to insufficient compensatory mechanism to 
vasoconstricitive and sodium retaining factors) predicted incident hypertension.
